Concentrix (NASDAQ:CNXC) Price Target Lowered to $26.00 at Bank of America

Concentrix (NASDAQ:CNXC) had its price target lowered by stock analysts at Bank of America from $32.00 to $26.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Bank of America‘s price objective suggests a potential upside of 20.85% from the stock’s current price.

Several other research analysts have also commented on the stock. Robert W. Baird dropped their price target on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research note on Tuesday. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a report on Monday, April 27th. Canaccord Genuity Group lowered their target price on shares of Concentrix from $55.00 to $45.00 and set a “buy” rating on the stock in a research report on Tuesday. Wall Street Zen lowered Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Finally, Barrington Research reduced their price target on Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research report on Tuesday. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Concentrix presently has a consensus rating of “Hold” and a consensus price target of $32.75.

Concentrix Stock Down 14.7%

Shares of Concentrix stock traded down $3.71 during trading on Tuesday, hitting $21.52. 4,628,495 shares of the stock traded hands, compared to its average volume of 1,649,366. The stock has a market cap of $1.31 billion, a P/E ratio of -1.00, a PEG ratio of 0.31 and a beta of 0.43. The company has a fifty day moving average price of $25.84 and a two-hundred day moving average price of $32.08. Concentrix has a twelve month low of $19.12 and a twelve month high of $62.14. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.18 and a current ratio of 1.18.

Concentrix (NASDAQ:CNXC) last released its quarterly earnings data on Monday, June 29th. The company reported $2.63 EPS for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The firm had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.47 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The company’s quarterly revenue was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Equities research analysts predict that Concentrix will post 10.42 EPS for the current fiscal year.

Insider Transactions at Concentrix

In other Concentrix news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total value of $133,500,000.00. Following the sale, the insider owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. This trade represents a 68.39% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Andre S. Valentine acquired 2,500 shares of Concentrix stock in a transaction dated Thursday, April 9th. The stock was acquired at an average cost of $27.95 per share, with a total value of $69,875.00. Following the completion of the transaction, the chief financial officer directly owned 89,066 shares of the company’s stock, valued at $2,489,394.70. This trade represents a 2.89% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Kopernik Global Investors LLC bought a new stake in Concentrix in the 1st quarter valued at $44,523,000. AQR Capital Management LLC increased its stake in shares of Concentrix by 25.5% in the second quarter. AQR Capital Management LLC now owns 4,305,469 shares of the company’s stock valued at $226,252,000 after buying an additional 875,556 shares in the last quarter. Pzena Investment Management LLC lifted its position in Concentrix by 32.3% during the 4th quarter. Pzena Investment Management LLC now owns 2,927,196 shares of the company’s stock worth $121,713,000 after buying an additional 714,604 shares in the last quarter. Quantinno Capital Management LP grew its stake in shares of Concentrix by 171.4% during the first quarter. Quantinno Capital Management LP now owns 1,076,413 shares of the company’s stock valued at $29,451,000 after purchasing an additional 679,749 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Concentrix by 28.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock valued at $103,588,000 after buying an additional 551,778 shares during the period. 90.34% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Concentrix said Q2 cash flow was strong, with record operating cash flow and adjusted free cash flow, and management highlighted growth in its iX Suite business and an AI-driven margin improvement plan. Concentrix Reports Second Quarter 2026 Results
• Neutral Sentiment: Analysts at Barrington Research and Robert W. Baird both lowered their price targets to $30 from higher levels, but kept outperform ratings, suggesting they still see upside despite the weaker near-term results. Analyst price target updates
• Negative Sentiment: Management cut full-year 2026 guidance to EPS of $10.83-$11.18 and revenue of $9.9 billion-$10.0 billion, both below analyst expectations, and also lowered Q3 guidance, signaling slower growth and pressure from clients trimming spend. Reuters article on forecast cut
• Negative Sentiment: Q2 results showed margins under pressure, with operating profit falling and cash from operations negative in one third-party breakdown, reinforcing concerns about profitability even as revenue rose modestly year over year. Benzinga pre-market movers article

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.